Published in Mol Cell Biol on August 01, 1986
Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J (2003) 5.61
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev (1998) 5.60
The ras-like yeast YPT1 gene is itself essential for growth, sporulation, and starvation response. Mol Cell Biol (1987) 2.58
Differential expression of the ras gene family in mice. Mol Cell Biol (1987) 2.07
Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc Natl Acad Sci U S A (1991) 1.44
Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol (1993) 1.34
Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects in various tissues. Mol Cell Biol (1989) 1.24
An overexpressed gene transcript in senescent and quiescent human fibroblasts encoding a novel protein in the epidermal growth factor-like repeat family stimulates DNA synthesis. Mol Cell Biol (1995) 1.24
An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal. Proc Natl Acad Sci U S A (1987) 1.17
Expression of c-fos and AP-1 activity in senescent human fibroblasts is not sufficient for DNA synthesis. J Cell Biol (1992) 1.12
Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response. Mech Ageing Dev (2009) 0.88
MRG15 activates the cdc2 promoter via histone acetylation in human cells. Exp Cell Res (2011) 0.82
The serial cultivation of human diploid cell strains. Exp Cell Res (1961) 25.11
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature (1983) 11.61
Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell (1982) 6.93
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature (1982) 6.78
Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature (1985) 6.41
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81
Viral oncogenes. Cell (1985) 5.20
The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid. Cell (1982) 4.66
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (1984) 4.61
Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry. Cell (1980) 4.35
Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell (1984) 3.81
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature (1983) 2.77
Evidence for the recessive nature of cellular immortality. Science (1983) 1.94
Characterization of cells transformed by Ad5/Ad12 hybrid early region I plasmids. Virology (1982) 1.90
Resistance of human cells to tumorigenesis induced by cloned transforming genes. Proc Natl Acad Sci U S A (1983) 1.79
Expression of SV40 T antigen in finite life-span hybrids of normal and SV40-transformed fibroblasts. Somatic Cell Genet (1981) 1.53
Ras p21 proteins with high or low GTPase activity can efficiently transform NIH/3T3 cells. Cell (1986) 1.51
Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells. Proc Natl Acad Sci U S A (1985) 1.31
Reinitiation of cellular DNA synthesis in BrdU-selected nondividing senescent WI-38 cells by simian virus 40 infection. J Cell Physiol (1985) 1.16
Senescent and quiescent cell inhibitors of DNA synthesis. Membrane-associated proteins. Exp Cell Res (1985) 1.16
Doubling potential, calendar time, and senescence of human diploid cells in culture. Exp Cell Res (1973) 1.11
Phenotype of low proliferative potential is dominant in hybrids of normal human fibroblasts. Somatic Cell Genet (1982) 1.09
Carcinogen-transformed human cells are inhibited from entry into S phase by fusion to senescent cells but cells transformed by DNA tumor viruses overcome the inhibition. Proc Natl Acad Sci U S A (1982) 1.09
Oncogenes and proto-oncogenes: how do they differ? J Natl Cancer Inst (1984) 1.08
Entry into S phase is inhibited in two immortal cell lines fused to senescent human diploid cells. Exp Cell Res (1979) 1.08
Reinitiation of DNA synthesis in senescent human fibroblasts upon fusion with cells of unlimited growth potential. J Cell Biol (1975) 0.95
Entry into S phase is inhibited in human fibroblasts by rat liver poly(A)+RNA. Exp Cell Res (1985) 0.93
Evidence for differences in the mechanism of cell cycle arrest between senescent and serum-deprived human fibroblasts: heterokaryon and metabolic inhibitor studies. J Cell Physiol (1984) 0.88
Inhibition of DNA synthesis in senescent-proliferating human cybrids is mediated by endogenous proteins. Exp Cell Res (1984) 0.86
Evidence for endogenous polypeptide-mediated inhibition of cell-cycle transit in human diploid cells. J Cell Biol (1982) 0.85
A long-lived human diploid fibroblast line for cellular aging studies: applications in cell hybridization. Mech Ageing Dev (1982) 0.84
Correlation between the presence of T-antigen and the reinitiation of host DNA synthesis in senescent human diploid fibroblasts after SV40 infection. Exp Cell Res (1983) 0.80
Induction of host DNA synthesis in senescent human diploid fibroblasts by infection with human cytomegalovirus. Mech Ageing Dev (1984) 0.79
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
Modulation of non-templated nucleotide addition by Taq DNA polymerase: primer modifications that facilitate genotyping. Biotechniques (1996) 8.92
Role of simian virus 40 gene A function in maintenance of transformation. J Virol (1975) 6.63
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res (1994) 6.16
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81
A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res (1991) 4.07
Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol (1989) 3.89
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85
CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev (1996) 3.27
The excretion of histamine in urine. J Physiol (1944) 3.23
The effect of arabinofuranosylcytosine on the growth cycle of simian virus 40. Virology (1965) 2.98
Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology (2000) 2.86
Hydrogen ion buffers for biological research. Anal Biochem (1980) 2.84
Replicative senescence: implications for in vivo aging and tumor suppression. Science (1996) 2.83
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA (1997) 2.73
Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp Cell Res (1989) 2.66
Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci U S A (1991) 2.64
Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A (1984) 2.44
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.41
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33
Multiple genes encode nuclear factor 1-like proteins that bind to the promoter for 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proc Natl Acad Sci U S A (1988) 2.31
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med (1992) 2.28
SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. Proc Natl Acad Sci U S A (1965) 2.27
A gene involved in control of human cellular senescence on human chromosome 1q. Mol Cell Biol (1994) 2.26
NeuralWISP: A Wirelessly Powered Neural Interface With 1-m Range. IEEE Trans Biomed Circuits Syst (2009) 2.23
Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci U S A (1988) 2.08
Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol (1991) 2.04
Subcellular Localization of simian virus 40 large tumor antigen. J Virol (1979) 2.03
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene (2000) 2.03
Non-specific urethritis associated with a tetracycline-resistant T-mycoplasma. Br J Vener Dis (1974) 2.01
Smokers' polycythemia. N Engl J Med (1978) 1.95
Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase. Biochim Biophys Acta (1975) 1.95
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95
Evidence for the recessive nature of cellular immortality. Science (1983) 1.94
Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol (2001) 1.88
Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol (1990) 1.80
Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells. J Bacteriol (1966) 1.79
A giant sauropod dinosaur from an Upper Cretaceous mangrove deposit in Egypt. Science (2001) 1.78
Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial. AIDS (1989) 1.78
Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells. J Virol (1989) 1.76
Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res (1972) 1.73
Intraclonal variation in proliferative potential of human diploid fibroblasts: stochastic mechanism for cellular aging. Science (1980) 1.72
Analysis by high density cDNA arrays of altered gene expression in human intestinal epithelial cells in response to infection with the invasive enteric bacteria Salmonella. J Biol Chem (2000) 1.70
Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1 alpha. J Clin Invest (1995) 1.68
Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. J Clin Invest (1997) 1.68
Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease. Br J Ophthalmol (2004) 1.66
HIV and infertility: time to treat. There's no justification for denying treatment to parents who are HIV positive. BMJ (2001) 1.62
Antenatal serum screening for genital herpes: a study of knowledge and attitudes of women at a central London hospital. Br J Obstet Gynaecol (1997) 1.62
Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62
Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology (1979) 1.61
Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J (1995) 1.59
Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol Cell Biol (1999) 1.57
Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol (2000) 1.56
Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog (1996) 1.56
Existence of high abundance antiproliferative mRNA's in senescent human diploid fibroblasts. Science (1986) 1.55
THE FLOW OF BLOOD IN THE CORONARY ARTERIES IN PATHOLOGICAL HEARTS. J Clin Invest (1938) 1.55
Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem Biophys Res Commun (1989) 1.54
The impact of child support on cognitive outcomes of young children. Demography (1998) 1.54
Expression of SV40 T antigen in finite life-span hybrids of normal and SV40-transformed fibroblasts. Somatic Cell Genet (1981) 1.53
Effects of short-term ethanol and nutrition on the hepatic microsomal monooxygenase system in a model utilizing total enteral nutrition in the rat. Alcohol Clin Exp Res (1991) 1.50
Protein content in lymph and edema fluid in congestive heart failure. Circulation (1969) 1.50
Conservation of the MORF4 related gene family: identification of a new chromo domain subfamily and novel protein motif. Gene (2001) 1.49
Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol Carcinog (1994) 1.49
Fibroid embolisation: a technique not without significant complications. BJOG (2000) 1.46
Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc Natl Acad Sci U S A (1991) 1.44
Management of intracranial meningeal hemangiopericytomas: outcome and experience. Neurosurg Rev (2006) 1.44
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Expression of angiotensin-converting enzyme activity in cultured pulmonary artery endothelial cells. J Cell Physiol (1981) 1.38
View 1: Assisted conception in couples with HIV infection. Sex Transm Infect (2003) 1.38
The molecular organisation of bimolecular lipid membranes. The dielectric structure of the hydrophilic/hydrophobic interface. Biochim Biophys Acta (1981) 1.37
Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology (1995) 1.37
Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol (1996) 1.37
The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J Biol Chem (1995) 1.37
Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology (1993) 1.36
Erythromycin ointment for ocular prophylaxis of neonatal chlamydial infection. JAMA (1980) 1.36
Toxicity assessment of sediments from the Grand Calumet River and Indiana Harbor Canal in Northwestern Indiana, USA. Arch Environ Contam Toxicol (2002) 1.31
Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc Natl Acad Sci U S A (1995) 1.31
Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol Cell Biol (1985) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30
Safety and pharmacokinetics of oseltamivir at standard and high dosages. Int J Antimicrob Agents (2010) 1.29
Variation in properties of plaque progeny of PARA (defective simian papovavirus 40)-adenovirus 7. J Virol (1969) 1.28